Giordano Michael F
Insider CIK 1733915 · EPZM Director · RAPT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,618 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 4,561 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 32,229 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 1,063 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 938 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 799 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 402 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 824 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 257,832 | — | $0 | 257,832 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2024-05-22 | 2024-05-23 | 36,490 | — | $0 | 36,490 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2023-05-25 | 12,940 | — | $0 | 12,940 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 8,994 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 8,060 | — | $0 | 8,994 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2022-05-25 | 2022-05-26 | 8,500 | — | $0 | 8,500 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 41,006 | — | $0 | 41,006 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2022-05-17 | 2022-05-19 | 8,994 | — | $0 | 17,054 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 3,213 | $16.80 | $54.0K | 3,213 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 40,559 | — | $0 | 40,559 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-06-11 | 2021-06-15 | 8,060 | — | $0 | 8,060 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2021-05-28 | 2021-06-24 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | M Exercise deriv | 2020-06-25 | 2020-06-26 | 8,944 | — | $0 | 6,390 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | M Exercise deriv | 2020-06-25 | 2020-06-26 | 10,069 | — | $0 | 6,597 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | M Exercise | 2020-06-25 | 2020-06-26 | 8,944 | $12.00 | $107.3K | 8,944 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | M Exercise | 2020-06-25 | 2020-06-26 | 10,069 | $6.18 | $62.2K | 10,069 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | S Sale | 2020-06-25 | 2020-06-26 | 19,013 | $33.37 | $634.5K | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 14,013 | — | $0 | 14,013 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2019-10-30 | 2019-11-01 | 15,334 | — | $0 | 15,334 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2019-05-31 | 2019-06-07 | 17,633 | — | $0 | 17,633 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-03-08 | 2018-03-12 | 25,000 | — | $0 | 25,000 | SEC↗ |